Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: 5′/ 3′ imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer

Fig. 2

Evaluation of the primers’ specificity for detection of the expression of the 3′/5′ portion of the ALK gene. (a-c) RT-PCR products of the 3′/5′ portion of the ALK gene from tumor tissues (a), PBMCs (b) and plasma (c) are shown on agarose gel. d and e show the expression of the 3′/5′ portion of the ALK gene, respectively, by RT-qPCR. f shows the expression of ACTB by RT-qPCR as a control. T = tumor tissue, PB = peripheral blood, P = plasma, E3: ALK gene exon 3; E20: ALK gene exon 20. ACTB: beta-actin

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us